Literature DB >> 625284

Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase.

P P Trotta, M P Ahland, G F Brown, M E Balis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 625284

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  5 in total

Review 1.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats.

Authors:  M E Stromski; A van Waarde; M J Avison; G Thulin; K M Gaudio; M Kashgarian; R G Shulman; N J Siegel
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  Deoxycoformycin toxicity in mice after long-term treatment.

Authors:  R P Agarwal
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Animal model for immune dysfunction associated with adenosine deaminase deficiency.

Authors:  A Tedde; M E Balis; S Ikehara; R Pahwa; R A Good; P P Trotta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

5.  The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

Authors:  E Richard; F X Arredondo-Vega; I Santisteban; S J Kelly; D D Patel; M S Hershfield
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.